Eylea 40mg (Aflibercept Vials) 40mg/ml

Eylea 40mg is a prescription medication used to treat eye conditions like wet age-related macular degeneration and diabetic macular edema. It contains aflibercept, a VEGF inhibitor, delivered in single-use vials. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance.

Strength

40mg/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Bayer AG Germany

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eylea 40mg is used to treat retinal disorders caused by abnormal blood vessel growth, such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME). It helps reduce fluid leakage and swelling in the retina, supporting vision maintenance. This medication is administered by a healthcare professional via injection into the eye.

Side Effects

After treatment with Eylea 40mg, many patients experience improved clarity in their vision over time. Some may notice reduced swelling or fewer dark spots in their field of view. Individual responses vary, and effects depend on the underlying condition being treated. Regular monitoring is recommended to assess progress.

Precautions & Warnings

Eylea 40mg should only be handled and administered by a qualified healthcare provider. Patients should inform their doctor of any allergies or eye infections before treatment. Keep the vial refrigerated at 2-8°C and protect it from light. Avoid shaking the vial to maintain its integrity.

Avoid Interactions

Eylea 40mg is administered directly into the eye, minimizing systemic interactions. However, patients should disclose all medications, including eye drops, to their healthcare provider. Certain conditions, such as infections or recent surgeries, may affect suitability. Always follow medical advice regarding concurrent treatments.

References

Frequently Asked Questions

Eylea 40mg is used to treat eye conditions like wet age-related macular degeneration and diabetic macular edema by reducing abnormal blood vessel growth.

Eylea 40mg is given as an injection into the eye by a healthcare professional in a clinical setting.

No, Eylea 40mg should be stored refrigerated between 2-8°C and protected from light until use.

Inform your doctor about any allergies, eye infections, or recent surgeries before starting Eylea 40mg treatment.

The dosing schedule for Eylea 40mg is determined by your healthcare provider based on your specific condition.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.